by Craig Weatherby
A study in mice virtually proves that inflammation is essential to creation of breast cancer.
The study involved mice genetically engineered to develop breast cancer, but in which researchers could block a key gene switch needed to trigger inflammation.
Mouse experiment proves that local inflammation drives creation of breast cancer.
Study used bio-engineered mice to pinpoint the inflammation-triggering gene “switch” responsible for cancer-promotion.
Omega-3s and food-borne polyphenols—such as in tea, berries, spices, olives, and cocoa—tend to suppress over-activation of this trigger.
The study targeted a particular gene “switch” called Nf-kappa B or NFKB, and its results prove that over-activation of NFKB is essential to formation of breast cancer… at least in mice, and very likely in women, too.
The landmark results showed that tumors would not develop when the inflammation-triggering NFKB switch was blocked selectively in the animals’ breast tissues (Liu M et al. 2010).
As a consequence, scientists from the Kimmel Cancer Center at Virginia’s Thomas Jefferson University say they’ve “definitively” shown that inflammation in the breast promotes growth of cancer stem cells responsible for tumor development.
Critically, the Kimmel team found that inactivating inflammation selectively within the breast reduced activity of these cancer stem cells, and stopped breast tumors from forming.
The study was funded by support from the National Institutes of Health, the Dr. Ralph and Marian C. Falk Medical Research Trust, and a grant from the Pennsylvania Department of Health.
“These studies show for the first time that inactivating the NFKB inflammatory pathway in the breast epithelium blocks the onset and progression of breast cancer in living animals,” said Richard G. Pestell, M.D., Ph.D., Director of the Kimmel Cancer Center and Chairman of Cancer Biology (TJU 2010).
Study co-author Michael Lisanti added the key point, saying, “This finding has clinical implications. Suppressing the whole body’s inflammatory process has side effects. These studies provide the rationale for more selective anti-inflammatory therapy directed just to the breast” (TJU 2010).
However, NFKB is necessary to human health, so the trick is to either block its activation only in breast tissues… or only in the specific, as yet unclear physiological contexts that cause the over-activation of NFKB now shown essential to cancer formation.
Findings encourage testing of anti-inflammatory diets and drugs
Although inflammation mediated by NFKB has long been thought to be important in breast cancer development, the theory had been un-testable because NFKB is essential to embryo development.
As Dr. Pestell said, “When you try to knock out NFKB genes in mice, they die” (TJU 2010).
He solved this problem by bio-engineering mice in which the inflammatory system within the adult animal’s normal breast could be regulated… which allowed selective inactivation of NFKB in different cell types.
They then demonstrated that this inactivation also reduced the number of cancer stem cells in the breast.
“That told us that inflammation, through the action of NFKB, is important to the growth and activity of cancer stem cells,” Dr. Pestell said (TJU 2010).
Because this research relied on genetic modifications, it obviously cannot be replicated in women.
But common food factors are known to moderate the pro-inflammatory NFKB gene switch identified in the study.
So it should be possible through testing to find the nutrients and food factors that block NFKB selectively enough to help prevent breast cancer while keeping women’s immune systems healthy.
And unlike any drugs discovered to date, moderate intake of food-borne polyphenols appears to only suppress NFKB when it is activated inappropriately … not when the inflammation it triggers is needed to fight an infection or address a wound.
NFKB: Needed, but dangerous when over-activated
NFKB is one of several families of proteins called nuclear transcription factors, which prompt cells to express certain genes. (For simplicity’s sake, we’ll follow standard practice and refer to the NFKB group as though it were one compound.)
In the case of NFKB, the genes it causes to be expressed stimulate immune-system cells to mount an inflammation response.
And as the author of a review article put it, chronic activation of NFKB, in the absence of real threat requiring an inflammation response, is dangerous to health: “…pathological dysregulation of NFKB is linked to inflammatory and autoimmune diseases as well as cancer” (Hooper C 2010).
Study pinpoints a particular NFKB pathway
There are two NFKB cell-signaling pathways, known as the “canonical” pathway and “non-canonical” routes.
The canonical pathway stimulates inflammation, while the non-canonical pathway enables the production of immune system cells called lymphocytes.
Dr. Pestell and his colleagues show that activation of the “canonical” NFKB pathway promotes breast cancer development.
The inflammatory cascade in the breast starts when the infamous HER2 gene activates NFKB, which stimulates pro-inflammatory immune cells (macrophages) that in turn produce tumor growth-promoting factors.
Researchers who contributed to the study included scientists from the National Cancer Institute, the Nigata University of Pharmacy and Applied Life Sciences in Japan, the University of Western Australia, and the Lombardi Comprehensive Cancer Center at Georgetown University Medical School.
Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vené R, Dell'Eva R, Jochum M, Albini A, Pfeffer U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem. 2007;19(1-4):137-52.
Beekwilder J, Hall RD, de Vos CH. Identification and dietary relevance of antioxidants from raspberry. Biofactors. 2005;23(4):197-205.
Carlton PS, Kresty LA, Siglin JC, Morse MA, Lu J, Morgan C, Stoner GD. Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis. 2001 Mar;22(3):441-6.
Chen T, Hwang H, Rose ME, Nines RG, Stoner GD. Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res. 2006 Mar 1;66(5):2853-9.
Hooper C. Overview of NFkB signaling: The latest immunology review, giving an overview of NFkB signaling in health and disease. Accessed at http://www.abcam.com/index.html?pageconfig=resource&rid=11255&pid=10629
Kiss A, Kowalski J, Melzig MF. Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B. Phytomedicine. 2006 Mar;13(4):284-9. Epub 2005 Jun 27.
Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, Gupta A, Blackwood M, Stoner GD. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 2001 Aug 15;61(16):6112-9.
Lin JK, Liang YC, Lin-Shiau SY. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol. 1999 Sep 15;58(6):911-5. Review.
Liu M, Li XQ, Weber C, Lee CY, Brown J, Liu RH. Antioxidant and antiproliferative activities of raspberries. J Agric Food Chem. 2002 May 8;50(10):2926-30.
Liu M, Sakamaki T, Mathew C et al. The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion. Cancer Res December 15, 2010 70:10464-10473; doi:10.1158/0008-5472.CAN-10-0732
Madhusoodhanan R, Natarajan M, Singh JV, Jamgade A, Awasthi V, Anant S, Herman TS, Aravindan N. Effect of black raspberry extract in inhibiting NFkappa B dependent radioprotection in human breast cancer cells. Nutr Cancer. 2010;62(1):93-104.
Meyers KJ, Watkins CB, Pritts MP, Liu RH. Antioxidant and antiproliferative activities of strawberries. J Agric Food Chem. 2003 Nov 5;51(23):6887-92.
Olsson ME, Andersson CS, Oredsson S, Berglund RH, Gustavsson KE. Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionally cultivated strawberries. J Agric Food Chem. 2006 Feb 22;54(4):1248-55.
Olsson ME, Gustavsson KE, Andersson S, Nilsson A, Duan RD. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem. 2004 Dec 1;52(24):7264-71.
Ramos S, Alia M, Bravo L, Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem. 2005 Feb 23;53(4):1271-80.
Reen RK, Nines R, Stoner GD. Modulation of N-nitrosomethylbenzylamine metabolism by black raspberries in the esophagus and liver of Fischer 344 rats. Nutr Cancer. 2006;54(1):47-57.
Ross HA, McDougall GJ, Stewart D. Antiproliferative activity is predominantly associated with ellagitannins in raspberry extracts. Phytochemistry. 2006 Nov 24; [Epub ahead of print]
Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem. 2005 Jun;16(6):360-7.
Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, Scheuller HS, Heber D. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem. 2006 Dec 13;54(25):9329-39.
Stoner GD, Chen T, Kresty LA, Aziz RM, Reinemann T, Nines R. Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer. 2006;54(1):33-46.
Thomas Jefferson University (TJU). Breast Inflammation is Key to Cancer Growth. December 15, 2010. Accessed at http://newswise.com/articles/breast-inflammation-is-key-to-cancer-growth
Wang SY, Feng R, Lu Y, Bowman L, Ding M. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.). J Agric Food Chem. 2005 May 18;53(10):4187-93.